51 related articles for article (PubMed ID: 8666327)
1. Crystals and cancer: good vibrations or bad intentions?
Harding V; Stebbing J
Lancet Oncol; 2014 Mar; 15(3):263-4. PubMed ID: 24599925
[No Abstract] [Full Text] [Related]
2. Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations.
Portincasa P; Di Ciaula A; Bonfrate L; Stella A; Garruti G; Lamont JT
Intern Emerg Med; 2023 Oct; 18(7):1897-1918. PubMed ID: 37455265
[TBL] [Abstract][Full Text] [Related]
3. Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.
Wang R; Nissen NN; Zhang Y; Shao C; Chu CY; Huynh C; Posadas EM; Tomlinson JS; Lewis MS; Pandol SJ
Front Physiol; 2022; 13():827531. PubMed ID: 35237181
[TBL] [Abstract][Full Text] [Related]
4. The physical presence of gallstone modulates
Portincasa P; van Erpecum KJ; Di Ciaula A; Wang DQ
Gastroenterol Rep (Oxf); 2019 Feb; 7(1):32-41. PubMed ID: 30792864
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal defects in gallstone and cholecystectomized patients.
Di Ciaula A; Molina-Molina E; Bonfrate L; Wang DQ; Dumitrascu DL; Portincasa P
Eur J Clin Invest; 2019 Mar; 49(3):e13066. PubMed ID: 30592298
[TBL] [Abstract][Full Text] [Related]
6. The hepatobiliary complications of malnutrition and nutritional support in adults.
McNeice A; Scott R; Rafferty GP; Cash WJ; Turner GB
Ir J Med Sci; 2019 Feb; 188(1):109-117. PubMed ID: 29850987
[TBL] [Abstract][Full Text] [Related]
7. Therapy of gallstone disease: What it was, what it is, what it will be.
Portincasa P; Ciaula AD; Bonfrate L; Wang DQ
World J Gastrointest Pharmacol Ther; 2012 Apr; 3(2):7-20. PubMed ID: 22577615
[TBL] [Abstract][Full Text] [Related]
8. Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.
Detzel CJ; Kim Y; Rajagopalan P
Tissue Eng Part A; 2011 Mar; 17(5-6):677-89. PubMed ID: 20929286
[TBL] [Abstract][Full Text] [Related]
9. Targets for current pharmacologic therapy in cholesterol gallstone disease.
Di Ciaula A; Wang DQ; Wang HH; Bonfrate L; Portincasa P
Gastroenterol Clin North Am; 2010 Jun; 39(2):245-64, viii-ix. PubMed ID: 20478485
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis: updates in diagnosis and therapy.
Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with a short bowel.
Nightingale JM
World J Gastroenterol; 2001 Dec; 7(6):741-51. PubMed ID: 11819867
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol crystallisation in bile.
Portincasa P; van Erpecum KJ; Vanberge-Henegouwen GP
Gut; 1997 Aug; 41(2):138-41. PubMed ID: 9301489
[No Abstract] [Full Text] [Related]
13. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile.
Venneman NG; Portincasa P; Vanberge-Henegouwen GP; van Erpecum KJ
Eur J Clin Invest; 2004 Oct; 34(10):656-63. PubMed ID: 15473890
[TBL] [Abstract][Full Text] [Related]
14. Rapid formation of cholesterol crystals in gallbladder bile is associated with stone recurrence after laparoscopic cholecystotomy.
Jüngst D; del Pozo R; Dolu MH; Schneeweiss SG; Frimberger E
Hepatology; 1997 Mar; 25(3):509-13. PubMed ID: 9049188
[TBL] [Abstract][Full Text] [Related]
15. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
Tudyka J; Wechsler JG; Mason R; Maier C
Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
[TBL] [Abstract][Full Text] [Related]
17. Pathways of cholesterol crystallization in model bile and native bile.
Portincasa P; Moschetta A; van Erpecum KJ; Calamita G; Margari A; vanBerge-Henegouwen GP; Palasciano G
Dig Liver Dis; 2003 Feb; 35(2):118-26. PubMed ID: 12747631
[TBL] [Abstract][Full Text] [Related]
18. Behavior of various cholesterol crystals in bile from patients with gallstones.
Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
